Vascular News and Research

RSS

Study results of NanoViricides anti-dengue drug candidates presented at NIH/NIAID sponsored conference

NanoViricides, Inc.announced today that Anil R. Diwan, PhD, President of the Company, gave a presentation on Friday, February 18th, that discussed the Company's anti-viral technology and more specifically, results from both in-vitro and in-vivo studies of its drug candidates against dengue virus infections that can potentially cause a fatal manifestation, viz. dengue hemorrhagic fever.

23 Feb 2011

Dual lab tests accurately predict vein graft blood clots in patients during CABG

A team of heart experts at Johns Hopkins has found that dual lab tests of blood clotting factors accurately predict the patients whose blood vessels, in particular veins implanted to restore blood flow to the heart during coronary artery bypass grafting, are more likely to fail or become clogged within six months.

23 Feb 2011

USPTO issues patent to Silence Therapeutics' siRNA technology

Silence Therapeutics plc announces the issuance of United States patent 7,893,245, titled "Interfering RNA Molecules," by the United States Patent and Trademark Office.

23 Feb 2011

HealthGrades recognizes America's 50 Best Hospitals for 2011

HealthGrades America's 50 Best Hospitals for 2011 were identified in a report issued today by the leading independent healthcare ratings organization. These hospitals demonstrated superior and sustained clinical quality over an eleven year time period, based on an analysis of more than 140 million Medicare patient records.

23 Feb 2011

Researchers find endothelial dysfunction can predict risk of coronary heart disease

A new study from the Libin Cardiovascular Institute at the University of Calgary's Faculty of Medicine is shedding light on an underlying cause of heart disease.

22 Feb 2011

Pieris: New interim PRS-050 Phase I data against cancer to be presented at Tri-Conference in California

Pieris AG announced today the upcoming presentation of new preclinical and interim Phase I clinical trial data for its PRS-050 Anticalin(r) program, currently under evaluation for the treatment of cancer.

22 Feb 2011

GORE PROPATEN Vascular Graft for hemodialysis access receives CE Mark approval

W. L. Gore & Associates announced the GORE PROPATEN Vascular Graft for hemodialysis access has received CE Mark. Arteriovenous Grafts are used to create a conduit for repeated blood access during hemodialysis, allowing blood to be withdrawn from the body and cleansed when a patient has End Stage Renal Disease, commonly referred to as kidney failure.

22 Feb 2011

Mayo Clinic re-accredited as Advanced Primary Stroke Center by TJC

Mayo Clinic was awarded the Gold Seal of Approval for stroke care and re-accredited as an Advanced Primary Stroke Center by The Joint Commission following an on-site review conducted Friday, Feb. 18.

21 Feb 2011

Study: Gender may not increase risk of heart attack deaths

A study led by the University of Michigan Cardiovascular Center shows being a woman may not increase your risk of dying from treatment for a severe heart attack.

21 Feb 2011

Investigational heart valve implanted in patient through small puncture hole in leg

Physicians at the Methodist DeBakey Heart & Vascular Center in Houston implanted a new investigational heart valve in a patient through a small puncture hole in the leg.

21 Feb 2011

Sorin Group achieves 100,000 Mitroflow Aortic Pericardial Heart Valve implantation milestone

Sorin Group, a global medical device company and a leader in the treatment of cardiovascular diseases, announced a major milestone today: more than 100,000 Mitroflow Aortic Pericardial Heart Valves have now been implanted worldwide.

21 Feb 2011

Researchers receive $2 million NIH grant to identify biomarkers in children with hemangiomas

A nearly $2 million grant from the National Institutes of Health will help investigators at Nationwide Children's Hospital search for biomarkers that may be linked to the development and outcome of hemangiomas, the most common soft tissue tumor in children.

21 Feb 2011

Swedish scientist: Social, physical and mental activities can minimize risk of dementia

As the average life span becomes longer, dementia becomes more common. Swedish scientist Laura Fratiglioni has shown that everyone can minimize his or her risk of being affected. Factors from blood pressure and weight to the degree of physical and mental activity can influence cognitive functioning as one gets older.

21 Feb 2011

Study: Low levels of Klotho protein may serve as early warning sign of CKD

Low levels of the anti-aging hormone Klotho may serve as an early warning sign of the presence of kidney disease and its deadly cardiovascular complications, according to findings by UT Southwestern Medical Center researchers.

18 Feb 2011

Signs of P.A.D. indicate increased risk of heart disease, heart attack, death

Approximately nine million Americans over the age of 50 are living with a disease that affects their legs and raises their risk of having a heart attack. Unfortunately, many with the disease do not even know they have it. February is Heart Month, and the Vascular Disease Foundation and its P.A.D. Coalition are urging Americans to listen to their legs and be alert to the signs of peripheral arterial disease, or P.A.D.

18 Feb 2011

New study: Fast food meal consumption can affect inflammatory responses in blood vessels

The effect of a high-fat meal on blood vessel walls can vary among individuals depending on factors such as their waist size and triglyceride levels, suggests new research at UC Davis.

17 Feb 2011

FDA approves GORE VIABAHN device to treat peripheral artery disease

W. L. Gore & Associates today announced it has received FDA approval for the GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface on a lower profile delivery system.

17 Feb 2011

Spectranetics fourth quarter revenues decrease 1% to $29.3 million

Spectranetics Corporation today reported financial results for the quarter and full year ended December 31, 2010.

17 Feb 2011

Doctor speaks on health effects of chronic inflammation

If your body is in a chronic state of inflammation, it can have serious effects on your cellular health, and has been linked to degenerative diseases including cancer, heart disease, diabetes, Alzheimer's and many others. Luckily, there are numerous ways to control chronic inflammation naturally and promote overall health in the process.

17 Feb 2011

FAK enzyme plays a key role in preparing lung tissue for metastatic development

A Massachusetts General Hospital study has identified a new role for an important enzyme in preparing lung tissue for the development of metastases.

17 Feb 2011

Vascular News and Research

Study results of NanoViricides anti-dengue drug candidates presented at NIH/NIAID sponsored conference

Dual lab tests accurately predict vein graft blood clots in patients during CABG

USPTO issues patent to Silence Therapeutics' siRNA technology

HealthGrades recognizes America's 50 Best Hospitals for 2011

Researchers find endothelial dysfunction can predict risk of coronary heart disease

Pieris: New interim PRS-050 Phase I data against cancer to be presented at Tri-Conference in California

GORE PROPATEN Vascular Graft for hemodialysis access receives CE Mark approval

Mayo Clinic re-accredited as Advanced Primary Stroke Center by TJC

Study: Gender may not increase risk of heart attack deaths

Investigational heart valve implanted in patient through small puncture hole in leg

Sorin Group achieves 100,000 Mitroflow Aortic Pericardial Heart Valve implantation milestone

Researchers receive $2 million NIH grant to identify biomarkers in children with hemangiomas

Swedish scientist: Social, physical and mental activities can minimize risk of dementia

Study: Low levels of Klotho protein may serve as early warning sign of CKD

Signs of P.A.D. indicate increased risk of heart disease, heart attack, death

New study: Fast food meal consumption can affect inflammatory responses in blood vessels

FDA approves GORE VIABAHN device to treat peripheral artery disease

Spectranetics fourth quarter revenues decrease 1% to $29.3 million

Doctor speaks on health effects of chronic inflammation

FAK enzyme plays a key role in preparing lung tissue for metastatic development

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News